BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31251217)

  • 1. Acute generalized exanthematous pustulosis associated with anti-interferon-γ neutralizing autoantibody-positive disseminated nontuberculous mycobacterial infection.
    Ogawa Y; Hasebe R; Ohnuma T; Sano S; Mitsui H; Shimada S; Ishihara H; Sakagami T; Kawamura T
    Eur J Dermatol; 2019 Jun; 29(3):339-341. PubMed ID: 31251217
    [No Abstract]   [Full Text] [Related]  

  • 2. Repurposing QuantiFERON for Detection of Neutralizing Interferon-γ Autoantibodies in Patients With Nontuberculous Mycobacterial Infections.
    Suárez I; Lehmann C; Gruell H; Graeb J; Kochanek M; Fätkenheuer G; Plum G; van Wengen A; van de Vosse E; Hartmann P; Hanitsch LG; Rybniker J
    Clin Infect Dis; 2017 Aug; 65(3):518-521. PubMed ID: 28430999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated Mycobacterium gordonae and Mycobacterium mantenii infection with elevated anti-IFN-γ neutralizing autoantibodies.
    Hase I; Morimoto K; Sakagami T; Kazumi Y; Ishii Y; van Ingen J
    J Infect Chemother; 2015 Jun; 21(6):468-72. PubMed ID: 25735882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Interferon-γ Neutralizing Autoantibodies Against Disseminated Nontuberculous Mycobacterial Disease.
    Aoki A; Sakagami T; Yoshizawa K; Shima K; Toyama M; Tanabe Y; Moro H; Aoki N; Watanabe S; Koya T; Hasegawa T; Morimoto K; Kurashima A; Hoshino Y; Trapnell BC; Kikuchi T
    Clin Infect Dis; 2018 Apr; 66(8):1239-1245. PubMed ID: 29126235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of QuantiFERON-TB Gold In-tube assay in screening for neutralizing anti-interferon-γ autoantibodies in patients with disseminated nontuberculous mycobacterial infection.
    Wu UI; Chuang YC; Sheng WH; Sun HY; Jhong YT; Wang JY; Chang SC; Wang JT; Chen YC
    Clin Microbiol Infect; 2018 Feb; 24(2):159-165. PubMed ID: 28694201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent atypical mycobacterial infections in the adult: think of autoantibodies against interferon-gamma !].
    Picque JB; Blot M; Binois R; Jeudy G; Simonet AL; Cagnon J; Mahy S; Duong M; Buisson M; Chavanet P; Piroth L
    Rev Med Interne; 2012 Feb; 33(2):103-6. PubMed ID: 22236500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as successful adjunct treatment in a patient with disseminated nontuberculous mycobacterial infection due to acquired anti-interferon-γ autoantibody.
    Czaja CA; Merkel PA; Chan ED; Lenz LL; Wolf ML; Alam R; Frankel SK; Fischer A; Gogate S; Perez-Velez CM; Knight V
    Clin Infect Dis; 2014 Mar; 58(6):e115-8. PubMed ID: 24336756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody.
    Furuya H; Ikeda K; Miyachi K; Nakamura K; Suzuki K; Furuta S; Tamachi T; Hirose K; Sakagami T; Nakajima H
    Rheumatology (Oxford); 2017 Jul; 56(7):1241-1243. PubMed ID: 28371927
    [No Abstract]   [Full Text] [Related]  

  • 9. Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
    Imoto W; Yamada K; Hajika Y; Okamoto K; Myodo Y; Niki M; Kuwabara G; Yamairi K; Shibata W; Yoshii N; Nakaie K; Yoshizawa K; Namikawa H; Watanabe T; Asai K; Moro H; Kaneko Y; Kawaguchi T; Itoh Y; Kakeya H
    BMC Infect Dis; 2020 Jun; 20(1):431. PubMed ID: 32563248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Nontuberculous Mycobacterial Infection in a Patient with Anti-IFN-γ Autoantibodies.
    Tanimizu M; Mizuno K; Hashimoto M
    Acta Med Okayama; 2017 Dec; 71(6):547-552. PubMed ID: 29276230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
    Wu UI; Wang JT; Sheng WH; Sun HY; Cheng A; Hsu LY; Chang SC; Chen YC
    Clin Microbiol Infect; 2020 Dec; 26(12):1684.e1-1684.e6. PubMed ID: 32120037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile-Onset Immunodeficiency Secondary to Anti-Interferon-Gamma Autoantibodies.
    Liew WK; Thoon KC; Chong CY; Tan NWH; Cheng DT; Chan BSW; Ng MSY; Das L; Arkachaisri T; Huang CH; Kuan JL; Chai LYA; Koh MJA
    J Clin Immunol; 2019 Jul; 39(5):512-518. PubMed ID: 31177358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.
    Phoompoung P; Ankasekwinai N; Pithukpakorn M; Foongladda S; Umrod P; Suktitipat B; Mahasirimongkol S; Kiertiburanakul S; Suputtamongkol Y
    PLoS One; 2017; 12(4):e0176342. PubMed ID: 28437431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent Mycobacterium abscessus infection secondary to interferon-γ autoantibodies.
    Naik R; Cortes JA
    Ann Allergy Asthma Immunol; 2016 May; 116(5):461-2. PubMed ID: 27009440
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial Infection.
    Yoshizawa K; Aoki A; Shima K; Tanabe Y; Koya T; Hasegawa T; Kikuchi T; Sakagami T
    J Clin Immunol; 2020 Feb; 40(2):399-405. PubMed ID: 32034574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review.
    Hase I; Morimoto K; Sakagami T; Ishii Y; van Ingen J
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):308-315. PubMed ID: 28633901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections.
    Chi CY; Lin CH; Ho MW; Ding JY; Huang WC; Shih HP; Yeh CF; Fung CP; Sun HY; Huang CT; Wu TS; Chang CY; Liu YM; Feng JY; Wu WK; Wang LS; Tsai CH; Ho CM; Lin HS; Chen HJ; Lin PC; Liao WC; Chen WT; Lo CC; Wang SY; Kuo CY; Lee CH; Ku CL
    Medicine (Baltimore); 2016 Jun; 95(25):e3927. PubMed ID: 27336882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated
    Chaononghin S; Visuttichaikit S; Apisarnthanarak A; Khawcharoenporn T
    Int J Mycobacteriol; 2020; 9(1):91-94. PubMed ID: 32474495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute generalized exanthematous pustulosis associated with Mycoplasma pneumoniae infection: a case report].
    Navarrete-Dechent C; Curi-Tuma M; Moll-Manzur C; Dossi MT; Manríquez JJ; González S; Fich F
    Rev Chilena Infectol; 2016 Feb; 33(1):66-70. PubMed ID: 26965881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [DISSEMINATED NONTUBERCULOUS MYCOBACTERIOSIS THAT IS POSITIVE FOR NEUTRALIZING ANTI-INTERFERON-GAMMA AUTOANTIBODIES: A NEW DISEASE CONCEPT BASED ON HOST FACTORS].
    Sakagami T
    Kekkaku; 2015 Jun; 90(6):561-4. PubMed ID: 26489159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.